{
    "id": "professional_medicine-220",
    "question": "A placebo-controlled clinical trial is conducted to assess whether a new antihypertensive drug is more effective than standard therapy. A total of 5000 patients with essential hypertension are enrolled and randomly assigned to one of two groups: 2500 patients receive the new drug and 2500 patients receive placebo. If the alpha is set at 0.01 instead of 0.05, which of the following is the most likely result?",
    "options": {
        "A": "Significant findings can be reported with greater confidence",
        "B": "The study will have more power",
        "C": "There is a decreased likelihood of a Type II error",
        "D": "There is an increased likelihood of statistically significant findings"
    },
    "answer": "A",
    "predict": "To answer this question, let's break down the key concepts involved: 1. **Alpha (\u03b1)**: This is the maximum probability of rejecting the null hypothesis when it is true. A smaller alpha level (e.g., 0.01) means a more stringent criterion for significance, requiring stronger evidence to reject the null hypothesis. 2. **Power**: This is the probability of detecting a statistically significant effect when there is one. Increasing the sample size (which we are doing by using 5000 patients instead of a smaller sample) generally increases the power of the study. 3. **Type II error**: This occurs when a study fails to detect an effect that is present. A smaller alpha level (e.g., 0.01) increases the likelihood of a Type II error, as it becomes harder to detect an effect when the alpha level is more stringent. Given these points, let's analyze the options: - A: If alpha is set at 0.01, the study will require stronger evidence to achieve significance, which means it may not detect a significant effect if one exists. So, this option is incorrect. - B: Increasing the sample size generally increases the power of the study, making it easier to detect an effect if one exists. Therefore, this option is incorrect. - C: A smaller alpha level (e.g., 0.01) increases the likelihood of a Type II error, not decreases it. Therefore, this option is incorrect. - D: A smaller alpha level (e.g., 0.01) increases the likelihood of statistically significant findings, as it requires stronger evidence to reject the null hypothesis. This is because the null hypothesis is rejected more rarely when the alpha level is more stringent. Therefore, the most likely result of changing the alpha level from 0.05 to 0.01 in a placebo-controlled clinical trial is: {\"step_by_step_thinking\": \"Changing the alpha level from 0.05 to 0.01 increases the likelihood of statistically significant findings as it requires stronger evidence to reject the null hypothesis.\", \"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 34.36938405036926
}